WEBER CHRISTOPHE PIERRE

PrivateCIK: 2011270

WEBER CHRISTOPHE PIERRE enters TAKEDA PHARMACEUTICAL CO LTD with 1.19M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderWEBER CHRISTOPHE PIERRECIK 2011270
DirectorOfficer· President and CEO
Since Mar 2026
1.19M
Baseline shares
100% direct
1.19M
Direct ownership
2 positions
96.63K
Derivative underlying
3 instruments
2
Security positions
All direct
Non-Derivative Holdings2

Ordinary Shares

Direct
Shares owned935.30K

American Depositary Shares

Direct
Shares owned253.43K
Total
1.19M direct1.19M
Derivative Holdings3

Tax Obligation Award

Direct
Underlying security
Ordinary Shares

Underlying shares

46.37K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Tax Obligation Award

Direct
Underlying security
Ordinary Shares

Underlying shares

17.30K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Tax Obligation Award

Direct
Underlying security
Ordinary Shares

Underlying shares

32.97K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Total

Underlying

96.63K

Owned

0.00

WEBER CHRISTOPHE PIERRE — Initial Ownership Disclosure (Form 3) Filed Mar 18, 2026 | Finecho